5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats

By Awabdy D.   Bryan-Lluka L.J.   Wanstall J.C.  

European Journal of Pharmacology, Vol. 459, Iss. 1, 2003-01 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Specific uptake of 5-hydroxytryptamine is reduced in lungs from hypoxic pulmonary hypertensive rats

By Jeffery T.K.   Bryan-Lluka L.J.   Wanstall J.C.  

European Journal of Pharmacology, Vol. 396, Iss. 2, 2000-05 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite

Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser

By Gobbi M.   Mennini T.  

European Journal of Pharmacology, Vol. 370, Iss. 1, 1999-04 ,pp. : 23-26

Elsevier

Access to resources Recommend Favorite

Barakol, a natural anxiolytic, inhibits striatal dopamine release but not uptake in vitro

By Thongsaard W.   Pongsakorn S.   Sudsuang R.   Bennett G.W.   Kendall D.A.   Marsden C.A.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 157-164

Elsevier

Access to resources Recommend Favorite

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission

By Haddjeri N.   De Montigny C.   Curet O.   Blier P.  

European Journal of Pharmacology, Vol. 343, Iss. 2, 1998-02 ,pp. : 179-192

Elsevier

Access to resources Recommend Favorite